Royal Manchester Children's HospitalManchester, UK.
The School of Medical SciencesFaculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Eur J Endocrinol. 2017 Mar;176(3):359-369. doi: 10.1530/EJE-16-0812. Epub 2017 Jan 10.
The management of paediatric craniopharyngiomas was traditionally complete resection (CR), with better reported tumour control compared to that by partial resection (PR) or limited surgery (LS). The subsequent shift towards hypothalamic sparing, conservative surgery with adjuvant radiotherapy (RT) to any residual tumour aimed at reducing neuroendocrine morbidity, has not been systematically studied. Hence, we reviewed the sequelae of differing management strategies in paediatric craniopharyngioma across three UK tertiary centres over four decades.
Meta-data was retrospectively reviewed over two periods before (1973-2000 (Group A: n = 100)) and after (1998-2011 (Group B: n = 85)) the introduction of the conservative strategy at each centre.
Patients had CR (A: 34% and B: 19%), PR (A: 48% and B: 46%) or LS (A: 16% and B: 34%), with trends reflecting the change in surgical approach over time. Overall recurrence rates between the two periods did not change (A: 38% vs B: 32%). More patients received RT in B than A, but recurrence rates were similar: for A, 28% patients received RT with 9 recurrences (32%); for B, 62% received RT with 14 recurrences (26%). However, rates of diabetes insipidus (P = 0.04), gonadotrophin deficiency (P < 0.001) and panhypopituitarism (P = 0.001) were lower in B than those in A. In contrast, post-operative obesity (BMI SDS >+2.0) (P = 0.4) and hypothalamic (P = 0.1) and visual (P = 0.3) morbidity rates were unchanged.
The shift towards more conservative surgery has reduced the prevalence of hormone deficiencies, including diabetes insipidus, which can be life threatening. However, it has not been associated with reduced hypothalamic and visual morbidities, which remain a significant challenge. More effective targeted therapies are necessary to improve outcomes.
儿童颅咽管瘤的传统治疗方法为完全切除术(CR),与部分切除术(PR)或有限手术(LS)相比,其肿瘤控制效果更好。此后,为了降低神经内分泌发病率,治疗方法逐渐转为下丘脑保护,采用保守手术联合辅助放疗(RT)切除任何残留肿瘤,但这种方法尚未得到系统研究。因此,我们在三个英国三级中心回顾了过去四十年中不同治疗策略在儿童颅咽管瘤中的治疗效果。
回顾性分析了两个时期的数据:1973 年至 2000 年(A 组:n=100)和 1998 年至 2011 年(B 组:n=85)在每个中心引入保守治疗策略前后的数据。
患者接受了 CR(A 组:34%,B 组:19%)、PR(A 组:48%,B 组:46%)或 LS(A 组:16%,B 组:34%),手术方法的变化趋势反映了时间的推移。两个时期的总体复发率没有变化(A 组:38%比 B 组:32%)。B 组接受 RT 的患者多于 A 组,但复发率相似:A 组 28%的患者接受 RT,9 例复发(32%);B 组 62%的患者接受 RT,14 例复发(26%)。然而,B 组的尿崩症(P=0.04)、促性腺激素缺乏症(P<0.001)和全垂体功能减退症(P=0.001)的发生率低于 A 组。相比之下,术后肥胖(BMI SDS>+2.0)(P=0.4)、下丘脑(P=0.1)和视觉(P=0.3)发病率没有变化。
向更保守的手术方法转变降低了包括致命性尿崩症在内的激素缺乏症的发生率。然而,这并没有降低下丘脑和视觉发病率,这些仍然是一个重大挑战。需要更有效的靶向治疗来改善治疗效果。